Condition

Xerophthalmia

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common interventions8

Lead sponsors shown2

Clinical trials

4 shown

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye SyndromeNCT06771427 · 2025-01-16

RECRUITING

Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's SyndromeNCT06475027 · 2024-07-01

NOT_YET_RECRUITING

VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's SyndromeNCT05656196 · 2023-04-01

COMPLETED

Performance of a Photoscreener for Vision Screening in a Haitian Pediatric PopulationNCT02655432 · 2016-01-01

WITHDRAWN

Common interventions

AcupunctureOTHER1 acupuncture GB20 or GB20 plus BL2OTHER1 Chinese herbal tea TBDESJSDRUG1 Chinese herbal tea VGH-DESJS-1OTHER1 Cyclopleged refractionPROCEDURE1 Ophthalmologic evaluationPROCEDURE1 Spot photoscreenerDEVICE1 TBDESJSOTHER1

Leading sponsors

Taipei Veterans General Hospital, Taiwan 3 Université de Montréal 1

Trial status mix

COMPLETED1

NOT_YET_RECRUITING1

RECRUITING1

WITHDRAWN1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.